|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 18 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-14 |
4 |
OE |
$17.86 |
$196,460 |
D/D |
11,000 |
334,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-17 |
4 |
AS |
$84.39 |
$3,516,227 |
D/D |
(41,666) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-17 |
4 |
OE |
$17.54 |
$730,822 |
D/D |
41,666 |
365,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-27 |
4 |
OE |
$14.39 |
$863,400 |
D/D |
60,000 |
383,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-27 |
4 |
AS |
$81.34 |
$4,880,448 |
D/D |
(60,000) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-28 |
4 |
AS |
$81.27 |
$4,875,990 |
D/D |
(60,000) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-28 |
4 |
OE |
$14.39 |
$863,400 |
D/D |
60,000 |
383,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-07 |
4 |
AS |
$82.52 |
$5,776,435 |
D/D |
(70,000) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-07 |
4 |
OE |
$21.51 |
$1,505,700 |
D/D |
70,000 |
393,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-08 |
4 |
AS |
$82.83 |
$5,797,806 |
D/D |
(70,000) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-08 |
4 |
OE |
$21.51 |
$1,505,700 |
D/D |
70,000 |
393,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-16 |
4 |
OE |
$17.54 |
$730,892 |
D/D |
41,670 |
365,038 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-16 |
4 |
AS |
$90.97 |
$3,790,795 |
D/D |
(41,670) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-21 |
4 |
OE |
$26.49 |
$1,847,519 |
D/D |
69,744 |
240,426 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-21 |
4 |
AS |
$87.56 |
$6,106,478 |
D/D |
(69,744) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-22 |
4 |
OE |
$26.49 |
$1,847,492 |
D/D |
69,743 |
240,425 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-22 |
4 |
AS |
$85.69 |
$5,976,515 |
D/D |
(69,743) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-12-29 |
4 |
OE |
$17.33 |
$69,320 |
D/D |
4,000 |
174,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-12-29 |
4 |
AS |
$83.84 |
$335,360 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-12-30 |
4 |
OE |
$17.33 |
$69,320 |
D/D |
4,000 |
174,682 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-12-30 |
4 |
A |
$100.27 |
$14,439 |
D/D |
144 |
1,069 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-12-30 |
4 |
AS |
$83.35 |
$333,400 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-06 |
4 |
OE |
$17.33 |
$69,320 |
D/D |
4,000 |
174,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-06 |
4 |
AS |
$87.19 |
$348,760 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-09 |
4 |
AS |
$89.79 |
$359,160 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
850 Records found
|
|
Page 18 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|